Sheathless acoustic based flow cell sorter for enrichment of rare cells

• Published in: Cytometry. Part A 2022-04, Vol.101 (4), p.311-324
• Main Authors: Wang, Ce, Ma, Yuting, Pei, Zhiguo, Song, Feifei, Zhong, Jinfeng, Wang, Yao, Yan, Xintao, Dai, Pu, Jiang, Yi, Qiu, Jianping, Shi, Mengdie, Wu, Xiaodong
• Format: Article
• Language: English
• Subjects: Abundance; Acoustic waves; Acoustics; Biomedical materials; Blood levels; bulk acoustic wave; Cell Separation; Erythrocytes; Female; Fetuses; Flow cytometry; Flow Cytometry - methods; Fluorescence; Gating; Genetic analysis; Humans; Interrogation; Lab-On-A-Chip Devices; Leukocytes; Lymphocytes; Male; Microfluidic Analytical Techniques - methods; microfluidic fluorescence activated cell sorting; Microfluidics; piezoelectric transducer; Pregnancy; rare cell; Sheaths; Standing waves; Stem cells; Tumor cells
• ISSN: 1552-4922; 1552-4930
• DOI: 10.1002/cyto.a.24521

Cell enrichment is a powerful tool in many kinds of cell research, especially in applications with low abundance cell types. In this work, we developed a microfluidic fluorescence activated cell sorting device that was able to perform on‐demand, low loss cell detection, and sorting. The chip utilizes three‐dimensional acoustic standing waves to position all cells in the same fluid velocity regime without sheath. When the cells pass through a laser interrogation region, the scattering and fluorescent signals are detected, translated and transported to software. The target cells are then identified by gating on the plots. Short bursts of standing acoustic waves are triggered by order from PC to sort target cells within predefined gating region. For very low abundance and rare labeled lymphocytes mixed with high concentration unlabeled white blood cells (WBCs), (1–100 labeled lymphocytes are diluted in 106 WBCs in 1 ml volume fluid), the device is able to remove more than 98% WBCs and recover labeled lymphocytes with efficiency of 80%. We further demonstrated that this device worked with real clinical samples by successfully isolating fetal nucleated red blood cells (FNRBCs) in the blood samples from pregnant women with male fetus. The obtained cells were sequenced and the expressions of (sex determining region Y) SRY genes were tested to determine fetal cell proportion. In genetic analysis, the proportion of fetal cells in the final picked sample is up to 40.64%. With this ability, the device proposed could be valuable for biomedical applications involving fetal cells, circulating tumor cells, and stem cells.